NCT00596271View on ClinicalTrials.gov

Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440

PHASE3CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

August 31, 2008

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

IC51

BIOLOGICAL

HAVRIX

OTHER

Placebo

All Listed Sponsors
lead

Valneva Austria GmbH

INDUSTRY

NCT00596271 - Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440 | Biotech Hunter | Biotech Hunter